News | June 29, 2011

Study Demonstrates Discrepancies in Nuclear Cardiology Reporting, Yet Improvement with ICANL Accreditation

June 29, 2011 — A new study from the Intersocietal Commission for the Accreditation of Nuclear Medicine Laboratories (ICANL) suggests that while noncompliance with reporting standards is found in the majority of nuclear cardiology laboratories throughout the U.S., facilities participating in the ICANL accreditation process demonstrate an increase in compliance over time.

According to the study, published June 19 in the <i>Journal of Nuclear Cardiology,</i> a majority of facilities (57.2 percent) were noncompliant with more than one of the required reporting elements. The data also demonstrated that there were identifiable site characteristics that define which laboratories are more likely to be noncompliant. For instance, certain regions of the United States and facility settings were associated with greater noncompliance.

Most significantly, the study demonstrates that the ICANL accreditation process has a significant impact on quality. Researchers found that as laboratories apply in subsequent three-year cycles, there is an increase in the compliance of the generated report with the national standards. This continuous improvement illustrates that feedback from the accreditation review is integrated by the laboratories into their daily process, thus completing the quality cycle.

Lead author Peter L. Tilkemeier, M.D., notes that while the ICANL accreditation process has been in existence since 1997, this is the first time that the quality of nuclear cardiology reports has been evaluated for compliance with the <i>ICANL Standards.</i>

“As the final report is the single most important part of a nuclear cardiology study, it is very powerful to learn through this study that accreditation is contributing greatly to nuclear cardiology facilities’ ability to improve their reports,” Tilkemeier said.

In the recent study, site characteristics and the 18 elements of the ICANL nuclear reporting standards were evaluated in 1,301 laboratories applying for accreditation during a one-year period, beginning Jan. 1, 2008. Of the 18 report elements, the most frequent noncompliant items were: missing date of report (26.4 percent), separate stress and imaging reports (23.6 percent), missing the route of administration of radiopharmaceutical (22.8 percent) and no mention of the defect size, severity, type and location using standardized terminology (19.8 percent).

The ICANL is an instrument driving the improvement process by promoting uniform performance among laboratories with different characteristics such as study volume, laboratory type and geographic location notes Mary Beth Farrell, MS, CNMT, director of nuclear and PET accreditation for the Intersocietal Accreditation Commission (IAC).

“By identifying specific noncompliant reporting elements and site characteristics associated with noncompliance, we can now target educational activities to help laboratories improve the quality of reporting and facilitate successful accreditation,” Farrell said.

A follow-up editorial written by Frans J. Th. Wackers, M.D., Ph.D., FASNC, entitled “The Art of Communicating: The Nuclear Cardiology Report” was published June 25 in the ;Journal of Nuclear Cardiology. The editorial confirms the analysis revealing that the majority of laboratories applying for ICANL accreditation demonstrate noncompliance with reporting standards. In addition, the editorial emphasizes the significance of the nuclear cardiologist’s responsibility to provide comprehensive and clinically useful reports.

A nonprofit organization established in 1997, the ICANL is dedicated to promoting quality nuclear cardiology, nuclear medicine and PET imaging in the delivery of health care by providing a peer review process of laboratory accreditation. The ICANL is a member of the IAC, a nonprofit organization that provides facility accreditation programs for vascular, echocardiography, nuclear cardiology/nuclear medicine/PET, magnetic resonance (MR), computed tomography (CT) and carotid stenting. The IAC is comprised of six member divisions, each ensuring quality patient care and promoting health care within a specific medical specialty, all dedicated to one common mission.

For more information: www.icanl.org

Related Content

Philips Launches IntelliSpace Discovery Research Platform at RSNA
Technology | Artificial Intelligence | November 20, 2018
Ahead of the 2018 Radiological Society of North America Annual Meeting (RSNA), Nov. 25-30 in Chicago, Royal Philips...
Bay Labs and Northwestern Medicine Enroll First Patient in AI Echocardiography Study
News | Cardiovascular Ultrasound | November 19, 2018
Medical artificial intelligence (AI) company Bay Labs and Northwestern Medicine announced that the first patient has...
Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...
GE Healthcare Recalls Millennium Nuclear Medicine Systems
News | Nuclear Imaging | November 15, 2018
GE Healthcare announced it is recalling its Millennium Nuclear Medicine Systems due to an incident in which the the top...
Life Image and Mendel.ai Bringing Artificial Intelligence to Clinical Trial Development
News | Artificial Intelligence | November 15, 2018
Life Image and Mendel.ai announced a new strategic partnership that will facilitate the adoption and enhancement of...
Artificial Intelligence Predicts Alzheimer's Years Before Diagnosis
News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
University of Missouri Research Reactor First U.S. I-131 Supplier in 30 Years

MURR is the only supplier of I 131 in the United States and the first U.S. supplier since the 1980s. Image courtesy of University of Missouri

News | Radiopharmaceuticals and Tracers | November 13, 2018
The University of Missouri Research Reactor (MURR) recently shipped its first batch of Iodine-131 (I-131), a...